TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has provided an announcement.
Fuso Pharmaceutical Industries, Ltd. reported its non-consolidated financial results for the six months ending September 30, 2025, showing a 5% increase in net sales compared to the previous year, despite a significant decline in operating and ordinary profits. The company forecasts a slight increase in net sales for the full fiscal year ending March 31, 2026, but anticipates a decrease in profits. The financial results reflect challenges in maintaining profitability amidst sales growth, which may impact stakeholder expectations and market positioning.
The most recent analyst rating on (JP:4538) stock is a Hold with a Yen2256.00 price target. To see the full list of analyst forecasts on Fuso Pharmaceutical Industries,Ltd. stock, see the JP:4538 Stock Forecast page.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is listed on the Tokyo Stock Exchange and is known for its commitment to providing high-quality pharmaceutical solutions.
Average Trading Volume: 26,750
Technical Sentiment Signal: Buy
Current Market Cap: Yen18.83B
For detailed information about 4538 stock, go to TipRanks’ Stock Analysis page.